Response to pegylated interferon plus ribavirin among HIV/hepatitis C virus-coinfected patients with compensated liver cirrhosis.
about
Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia.Sustained virological response to peginterferon therapy in patients infected with HCV (genotypes 2 and 3), with or without HIV.Cost-Effectiveness of Hepatitis C Treatment for People Who Inject Drugs and the Impact of the Type of Epidemic; Extrapolating from Amsterdam, the NetherlandsVirological response rates for telaprevir-based hepatitis C triple therapy in patients with and without HIV coinfection.Latest pharmacotherapy options for treating hepatitis C in HIV-infected patients.Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1-coinfected patients.All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort.Liver stiffness predicts the response to direct-acting antiviral-based therapy against chronic hepatitis C in cirrhotic patients.HCV RNA viral load is independent from CD4 cell count and plasma HIV RNA viral load in immunocompetent HIV-HCV co-infected patients: a 3-years follow-up study.Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus-coinfected patients with compensated cirrhosis.
P2860
Q33423922-80B57B40-A6D2-45E1-A346-0E0D82D1C332Q34163411-2C979110-51F9-4F85-A3D5-9FDF0A766C0AQ36155257-076A9986-4511-4C4E-9DA1-A3F3DEFF41B1Q37626197-9A12659D-34CA-4336-AE9B-540A3D6FA21DQ38236179-02A3D084-5556-4FBF-A23D-DE5B3680062CQ39249225-2610EAE8-E28F-4F9C-B580-C413B8AB3B50Q39673593-217A5242-9F3E-40BF-BAFC-29D523B7FDD3Q40399465-B60D1679-6279-4D8B-A272-0992A5A723C0Q41984358-2077FBD0-97A5-44D1-8213-B14AD7720BFAQ42989479-B6A1ED9D-7564-41EA-819D-4B5E749DE92C
P2860
Response to pegylated interferon plus ribavirin among HIV/hepatitis C virus-coinfected patients with compensated liver cirrhosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Response to pegylated interfer ...... h compensated liver cirrhosis.
@en
Response to pegylated interfer ...... h compensated liver cirrhosis.
@nl
type
label
Response to pegylated interfer ...... h compensated liver cirrhosis.
@en
Response to pegylated interfer ...... h compensated liver cirrhosis.
@nl
prefLabel
Response to pegylated interfer ...... h compensated liver cirrhosis.
@en
Response to pegylated interfer ...... h compensated liver cirrhosis.
@nl
P2093
P2860
P50
P356
P1476
Response to pegylated interfer ...... h compensated liver cirrhosis.
@en
P2093
Antonio Rivero
Dolores Merino
Ignacio de los Santos-Gil
José A Girón-González
José A Mira
Luis F López-Cortés
Manuel Márquez
María J Ríos-Villegas
Silvia García-Rey
P2860
P304
P356
10.1093/CID/CIS779
P407
P577
2012-09-05T00:00:00Z